News & Publications
Our latest press release
27 January 2016
Launch of the EHVA consortia funded by the EU H2020 program
The European HIV Vaccine Alliance (EHVA) is a project funded by EU H2020 program. Its primary objective is to develop a multidisciplinary platform to evaluate novel preventive and therapeutic vaccines. EuroVacc provides the support in the scientific project management.
Read press release: English French
Our latest scientific publications
Asbach B et al.
Streamlining Heterologous DNA-Prime and NYVAC/Protein-Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.Journal of Virology. Feb 2016
Obuku AE et al.
Effect of Schistosoma mansoni infection on innate and HIV-1 specific T cell immune responses in HIV-1 infected Ugandan fisher folk. AIDS Res Hum Retroviruses. Feb 2016